Correction to: Nature Medicine https://doi.org/10.1038/s41591-024-03282-2, published online 1 October 2024.
In the version of the article initially published, in Table 1, the “EO14” row was included in cohort B when it should have been part of cohort A. The amended table can now be found in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Pan, J., Tan, Y., Shan, L. et al. Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial. Nat Med 31, 352 (2025). https://doi.org/10.1038/s41591-024-03348-1
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41591-024-03348-1
